HOSPITALIZATION COSTS DUE TO SEVERE ACUTE RESPIRATORY INFECTION (SARI) IN THREE CENTRAL AMERICAN COUNTRIES
Author(s)
Alvis-Guzmán N1, Marin-Correa C2, Castañeda-Orjuela C2, Sanchez-Ruiz C3, Carrasquilla-Sotomayor M4, Sanchez F5, Mena R6, Mejía H7
1Universidad de Cartagena. Centro de Investigación y Docencia. Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, Colombia, 2Instituto Nacional de Salud, BOGOTA D.C., Colombia, 3TEPHINET, Bogota D.C., Colombia, 4Universidad de Cartagena, Centro de Investigación y Docencia, Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, Colombia, 5Universidad Autonoma de Nicaragua, Managua, Nicaragua, 6Hospital General San Juan de Dios, San Lucas Sacatepequez, Guatemala, 7Secretaría de Salud, Tegucigalpa, Honduras
OBJECTIVES: To estimate the direct medical costs of severe acute respiratory infection (SARI) in children and adults from three Central American countries whit a bottom-up costing approach. METHODS: The costs of inpatients treatment were estimated through the retrospective bottom-up costing in a randomized sample of clinical records from SARI patients treated in teaching tertiary hospitals during 2009 - 2011 period. Activities incurred per patient were registered and a setting-specific cost per activity was acquired. Average cost per patient in the group of children and elderly adults was estimated for each country. In Nicaragua, only the pediatric population was included. Costs were expressed in local currency (2011), American dollars, and international dollars (2005) for country comparison. RESULTS: The care cost per case in children in Guatemala was the cheaper (I$971.95) compared to Nicaragua (I$1,431.96) and Honduras (I$1,761.29). In adults, the treatment cost for Guatemala was the more expensive: I$4,065.00 vs. I$2,707.91 in Honduras. CONCLUSIONS: Bottom-up costing of SARI cases allowed the mean estimates per treated case that could have external validity for the target population diagnosed in hospitals with similar epidemiological profiles and level of complexity for the study countries. This information is very relevant for the decision-making.
Conference/Value in Health Info
2015-05, ISPOR 2015, Philadelphia, PA, USA
Value in Health, Vol. 18, No. 3 (May 2015)
Code
PHS36
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Infectious Disease (non-vaccine)
Explore Related HEOR by Topic